PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery
Clinical trial NCT05468138 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05468138
- Sponsor
- Fudan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2029-02-28
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.